New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver dysfunction and a significant global health problem with substantial rise in prevalence over the last decades. It is becoming increasingly clear that NALFD is not only predominantly a hepatic manifestation of metabolic syndrome, but also involves extra-hepatic organs and regulatory pathways. Therapeutic options are limited for the treatment of NAFLD. Accordingly, a better understanding of the pathogenesis of NAFLD is critical for gaining new insight into the regulatory network of NAFLD and for identifying new targets for the prevention and treatment of NAFLD. In this review, we emphasize on the current understanding of the inter-organ crosstalk between the liver and peripheral organs that contributing to the pathogenesis of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099 · cited 1×
“…communication and a number of pathophysiological events in various types of cells via horizontal transfer of their cargo including proteins (membrane, cytosolic, and nuclear), RNAs (including mRNAs and microRNAs), and lipids (Yuan et al., 2009, Diehl et al., 2012, Raposo and Stoorvogel, 2013).”
BackgroundCentral nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451 · cited 1×
“More specifically, the ARC of hypothalamus is a specific nuclear group to sense different peripheral indicators of metabolic status and integrates responses to afferent information to control food intake and body weight (Schwartz et al., 2000).”
Backgroundden Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048 · cited 2×
“However, SCFAs also improve lipid and glucose metabolism and maintain intestinal homeostasis (den Besten et al., 2013, Puertollano et al., 2014, Boursier and Diehl, 2015).”
BackgroundYamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · cited 1×
“Different theories have been proposed; initially, the “two hits” hypothesis was developed to explain the pathogenesis of the NAFLD spectrum (Day and James, 1998).”
BackgroundDonnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 1×
“Additionally, β-oxidation of FFAs is inhibited in insulin resistance states, thus further promoting hepatic lipid accumulation (Donnelly et al., 2005, Postic and Girard, 2008, Cohen et al., 2011, Lambert et al., 2014).”
BackgroundWeyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119 · cited 2×
“This lipotoxicity is believed to further lead to mitochondrial dysfunction with oxidative stress and the production of reactive oxygen species (ROS) and ER stress-associated mechanisms (Malhotra and Kaufman, 2007, Vonghia et al., 2013, Schneider and Cuervo, 2014, Buzzetti et al., 2016).”
BackgroundAdiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824 · cited 1×
“In addition to that adiponectin improves hepatic and peripheral insulin resistance, it also presents some anti-inflammatory and hepato-protective activities (Kadowaki et al., 2006).”
BackgroundThe adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Microbiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457 · cited 1×
“Experiments comparing the feces of obese and lean individuals demonstrated that the level of short-chain fatty acids was higher in the obese whereas residual calories from food were concomitantly reduced (Turnbaugh et al., 2006, Schwiertz et al., 2010).”
BackgroundInflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435 · cited 2×
“Studies on TLR-4 null mice have confirmed that TLR-4 is essential for hepatic fat deposition and NASH development (Poggi et al., 2007, Saberi et al., 2009, Henao-Mejia et al., 2012).”
BackgroundLocal and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · cited 1×
“Data from human and animal studies have indicated that TNF-α has a role in the development of NAFLD and is a predictor of NASH that is correlated with advanced stages (Diehl, 2004, Cai et al., 2005, Jarrar et al., 2008).”
BackgroundHuman Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · cited 11×
“…undergo acyl-CoA synthetic activity to form fatty acyl-CoAs, which further be oxidized in mitochondria via the β-oxidation pathway, reesterified to TAG, and stored in lipid droplets (LDs) or coupled to apolipoproteins and further secreted as very lowdensity lipoprotein (VLDL) (Cohen et al., 2011).”
BackgroundInfluentialTargeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819 · cited 2×
“Specifically, FXR, originally named for its ability to bind to farnesoid, has shown to play a role in the regulation of lipid metabolism (Sinal et al., 2000, Schaap et al., 2014, Carr and Reid, 2015, Mazuy et al., 2015, Fuchs et al., 2016).”
BackgroundIncreased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434 · cited 2×
“The first evidence of an increased intestinal permeability (leaky gut) and tight junction alterations in NAFLD patients compared with healthy subjects was reported in 2009 (Miele et al., 2009).”
BackgroundVisceral fat adipokine secretion is associated with systemic inflammation in obese humans
Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E., & Klein, S. (2007) · Diabetes · doi:10.2337/db06-1656 · Cited by 1,417 · cited 1×
“Furthermore, large quantities of IL-6 are secreted by visceral fat than by subcutaneous fat in obese individuals (Fontana et al., 2007).”
BackgroundHypothalamic IKKβ/NF-κB and ER Stress Link Overnutrition to Energy Imbalance and Obesity
Zhang, X., Zhang, G., Zhang, H., Karin, M., Bai, H., & Cai, D. (2008) · Cell · doi:10.1016/j.cell.2008.07.043 · Cited by 1,350
Self-citationXu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317797 · Cited by 1,298
De Souza, C. T., Araujo, E. P., Bordin, S., Ashimine, R., Zollner, R. L., Boschero, A. C., Saad, M. J. A., & Velloso, L. A. (2005) · Endocrinology · doi:10.1210/en.2004-1520 · Cited by 1,171
Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons
Hahn, T. M., Breininger, J. F., Baskin, D. G., & Schwartz, M. W. (1998) · Nature Neuroscience · doi:10.1038/1082 · Cited by 1,164 · cited 1×
“…and cocaineamphetamine-regulated transcript (CART) are both activated by leptin (Cone et al., 1996, Kristensen et al., 1998), whereas orexigenic neuropeptide Y (NPY) and Agouti-related peptide (AgRP) are inhibited by leptin and activated by ghrelin (Broberger et al., 1998, Hahn et al., 1998).”
BackgroundMilanski, M., Degasperi, G., Coope, A., Morari, J., Denis, R., Cintra, D. E., Tsukumo, D. M. L., Anhe, G., Amaral, M. E., Takahashi, H. K., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2760-08.2009 · Cited by 1,125
Interplay between lipids and branched-chain amino acids in development of insulin resistance
Newgard, C. B. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.024 · Cited by 1,080 · cited 1×
“Branched-chain fatty acids, which can be de novo synthesized by several gut bacterial species, have been associated with insulin resistance and metabolic disease development (Newgard, 2012, Boursier and Diehl, 2015).”
BackgroundLambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069 · cited 1×
“Additionally, β-oxidation of FFAs is inhibited in insulin resistance states, thus further promoting hepatic lipid accumulation (Donnelly et al., 2005, Postic and Girard, 2008, Cohen et al., 2011, Lambert et al., 2014).”
BackgroundFetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S., Majumdar, S. S., & Bhattacharya, S. (2012) · Nature Medicine · doi:10.1038/nm.2851 · Cited by 922 · cited 1×
“There is a suggestion that fetuin-A constitutes a link between obesity, insulin resistance and NAFLD, plays a major pathogenic role in metabolic disease (Mori et al., 2011, Pal et al., 2012, Stefan and Haring, 2013).”
BackgroundReceptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892 · cited 3×
“These effects are partly achieved by enhancing the deacylation of ceramide sphingolipids, independently of AMPK, especially in hepatocytes (Holland et al., 2011b).”
BackgroundResultPsichas, A., Sleeth, M. L., Murphy, K. G., Brooks, L., Bewick, G. A., Hanyaloglu, A. C., Ghatei, M. A., Bloom, S. R., & Frost, G. (2015) · International Journal of Obesity · doi:10.1038/ijo.2014.153 · Cited by 886
Broberger, C., Johansen, J., Johansson, C., Schalling, M., & Hökfelt, T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.15043 · Cited by 798 · cited 1×
“…and cocaineamphetamine-regulated transcript (CART) are both activated by leptin (Cone et al., 1996, Kristensen et al., 1998), whereas orexigenic neuropeptide Y (NPY) and Agouti-related peptide (AgRP) are inhibited by leptin and activated by ghrelin (Broberger et al., 1998, Hahn et al., 1998).”
BackgroundThe role of pH in determining the species composition of the human colonic microbiota
Duncan, S. H., Louis, P., Thomson, J. M., & Flint, H. J. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01931.x · Cited by 786
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K.-I., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., et al. (2013) · Nature · doi:10.1038/nature12656 · Cited by 757
Mitochondrial dysfunction in Nash: causes, consequences and possible means to prevent it
Begriche, K., Igoudjil, A., Pessayre, D., & Fromenty, B. (2006) · Mitochondrion · doi:10.1016/j.mito.2005.10.004 · Cited by 753 · cited 8×
“Consequentially, increased ROS causes not only oxidative stress damage, but also the activation of Kupffer cells, whose activation is a key step in the development of NASH (Vonghia et al., 2013).”
BackgroundInfluentialLi, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733 · cited 2×
“This article is an open access publication P ro te in & C e ll as a novel hormone, leading to beneficial effects on glucose metabolism and lipid homeostasis, in addition to promoting rapid body weight loss in rodents (Li et al., 2010a).”
BackgroundHolland, W. L., Bikman, B. T., Wang, L.-P., Yuguang, G., Sargent, K. M., Bulchand, S., Knotts, T. A., Shui, G., Clegg, D. J., Wenk, M. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43378 · Cited by 705 · cited 3×
“These effects are partly achieved by enhancing the deacylation of ceramide sphingolipids, independently of AMPK, especially in hepatocytes (Holland et al., 2011b).”
BackgroundResultBile acid receptors as targets for drug development
Schaap, F. G., Trauner, M., & Jansen, P. L. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.151 · Cited by 696 · cited 1×
“Specifically, FXR, originally named for its ability to bind to farnesoid, has shown to play a role in the regulation of lipid metabolism (Sinal et al., 2000, Schaap et al., 2014, Carr and Reid, 2015, Mazuy et al., 2015, Fuchs et al., 2016).”
BackgroundBile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.28709 · Cited by 634 · cited 1×
“FXR-KO mice exhibit a proatherogenic lipoprotein profile with markedly elevated serum and hepatic cholesterol and triglycerides levels (Sinal et al., 2000, Arab et al., 2017).”
BackgroundPosey, K. A., Clegg, D. J., Printz, R. L., Byun, J., Morton, G. J., Vivekanandan-Giri, A., Pennathur, S., Baskin, D. G., Heinecke, J. W., Woods, S. C., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90377.2008 · Cited by 586
Pirola, C. J., Fernández Gianotti, T., Castaño, G. O., Mallardi, P., San Martino, J., Mora Gonzalez Lopez Ledesma, M., Flichman, D., Mirshahi, F., Sanyal, A. J., & Sookoian, S. (2015) · Gut · doi:10.1136/gutjnl-2014-306996 · Cited by 564 · cited 1×
“…miRNAs measured in 47 NASH patients, 30 individuals with simple steatosis and 19 healthy controls, levels of miR-122, miR-192, and miR-375 were upregulated in patients with NASH compared to those with simple steatosis, and were associated with histological disease severity (Pirola et al., 2015).”
BackgroundKleinridders, A., Schenten, D., Könner, A. C., Belgardt, B. F., Mauer, J., Okamura, T., Wunderlich, F. T., Medzhitov, R., & Brüning, J. C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.013 · Cited by 483 · cited 2×
“…hypothalamic inflammation was first reported in a rat model of diet-induced obesity (De Souza et al., 2005), which was further confirmed by other groups (Zhang et al., 2008, Kleinridders et al., 2009, Milanski et al., 2009, Ozcan et al., 2009, Posey et al., 2009, Holland et al., 2011a).”
BackgroundResultCoppari, R., Ichinose, M., Lee, C. E., Pullen, A. E., Kenny, C. D., McGovern, R. A., Tang, V., Liu, S. M., Ludwig, T., Chua, S. C., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.004 · Cited by 457
Saberi, M., Woods, N.-B., de Luca, C., Schenk, S., Lu, J. C., Bandyopadhyay, G., Verma, I. M., & Olefsky, J. M. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.006 · Cited by 456 · cited 1×
“Studies on TLR-4 null mice have confirmed that TLR-4 is essential for hepatic fat deposition and NASH development (Poggi et al., 2007, Saberi et al., 2009, Henao-Mejia et al., 2012).”
BackgroundTransfer of MicroRNAs by Embryonic Stem Cell Microvesicles
Yuan, A., Farber, E. L., Rapoport, A. L., Tejada, D., Deniskin, R., Akhmedov, N. B., & Farber, D. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004722 · Cited by 416 · cited 1×
“…communication and a number of pathophysiological events in various types of cells via horizontal transfer of their cargo including proteins (membrane, cytosolic, and nuclear), RNAs (including mRNAs and microRNAs), and lipids (Yuan et al., 2009, Diehl et al., 2012, Raposo and Stoorvogel, 2013).”
BackgroundPnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis
Smagris, E., BasuRay, S., Li, J., Huang, Y., Lai, K. V., Gromada, J., Cohen, J. C., & Hobbs, H. H. (2015) · Hepatology · doi:10.1002/hep.27242 · Cited by 379 · cited 4×
“…fat content in mice, whereas transgenic mice with hepatic specific overexpression of human 148M or PNPLA3 I148M knock-in mice exhibit increased hepatic TAG contents and LD sizes and develop hepatic steatosis (Basantani et al., 2011, Li et al., 2012, Pirazzi et al., 2012, Smagris et al., 2015).”
BackgroundInfluentialSelf-citationGäbele, E., Dostert, K., Hofmann, C., Wiest, R., Schölmerich, J., Hellerbrand, C., & Obermeier, F. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.035 · Cited by 324 · cited 1×
“Since then, more studies in humans and mice have confirmed the association between impaired intestinal barrier function and hepatic fibrogenesis and inflammation (Miele et al., 2009, Gabele et al., 2011).”
BackgroundCirculating leptin in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Polyzos, S. A., Aronis, K. N., Kountouras, J., Raptis, D. D., Vasiloglou, M. F., & Mantzoros, C. S. (2016) · Diabetologia · doi:10.1007/s00125-015-3769-3 · Cited by 248 · cited 1×
“Importantly, such increased leptin levels were consistent with the severity of NAFLD, and the association remains significant after the exclusion of pediatric or adolescent populations as well as morbidly obese individuals subjected to bariatric surgery (Polyzos et al., 2016).”
BackgroundInsulin-independent regulation of hepatic triglyceride synthesis by fatty acids
Vatner, D. F., Majumdar, S. K., Kumashiro, N., Petersen, M. C., Rahimi, Y., Gattu, A. K., Bears, M., Camporez, J.-P. G., Cline, G. W., Jurczak, M. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423952112 · Cited by 235 · cited 1×
“Selective hepatic insulin resistance has been proposed to explain the common clinical phenotype of hyperglycemia, hyperlipidemia, and NAFLD in T2D patients (Vatner et al., 2015).”
BackgroundCirculating fetuin-A and free fatty acids interact to predict insulin resistance in humans
Stefan, N., & Häring, H.-U. (2013) · Nature Medicine · doi:10.1038/nm.3116 · Cited by 160 · cited 1×
“There is a suggestion that fetuin-A constitutes a link between obesity, insulin resistance and NAFLD, plays a major pathogenic role in metabolic disease (Mori et al., 2011, Pal et al., 2012, Stefan and Haring, 2013).”
BackgroundNuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease
Fuchs, C., Traussnigg, S., & Trauner, M. (2016) · Seminars in Liver Disease · doi:10.1055/s-0036-1571296 · Cited by 100
Hepatokines and non-alcoholic fatty liver disease
Lebensztejn, D. M., Flisiak-Jackiewicz, M., Białokoz-Kalinowska, I., Bobrus-Chociej, A., & Kowalska, I. (2016) · Acta Biochimica Polonica · doi:10.18388/abp.2016_1252 · Cited by 90
Cited by
Macrophage Polarization and Its Role in Liver Disease
Wang, C., Ma, C., Gong, L., Guo, Y., Fu, K., Zhang, Y., Zhou, H., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803037 · Cited by 581
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Pafili, K., & Roden, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101122 · Cited by 330
Impact of different ectopic fat depots on cardiovascular and metabolic diseases
Ferrara, D., Montecucco, F., Dallegri, F., & Carbone, F. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28821 · Cited by 195
The cellular function of SCAP in metabolic signaling
Lee, S. H., Lee, J.-H., & Im, S.-S. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0430-0 · Cited by 96
Altered lipid metabolism as a predisposing factor for liver metastasis in MASLD
Kim, S. J., & Hyun, J. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100010 · Cited by 30
Metadata
- Authors
- Zhang, X., Ji, X., Wang, Q., & Li, J. Z.
- Venue
- Protein & Cell
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-06-22
- Volume
- 9
- Issue
- 2
- Pages
- 164-177
- ISSN
- 1674-800X (ISSN-L)
- 1674-8018
- OpenAlex
- W2721426985
- Cited by
- 130
- References
- 53
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.